NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats

Brain Research

Volumn 1391, Issue , 2011, Pages 102-113

  Shang, Ai Jia ^a,b   Hong, Sun Quan ^b   Xu, Qiang ^a   Wang, Hang Yan ^a   Yang, Ying ^a   Wang, Zhong Feng ^c   Xu, Bai Nan ^a   Jiang, Xiao Dan ^b   Xu, Ru Xiang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Mesenchymal stromal cells; Nerve growth factors; Spinal cord injury; Transplantation; Umbilical cord

Indexed keywords

FIBRONECTIN; GREEN FLUORESCENT PROTEIN; HERMES ANTIGEN; NEUROTROPHIN 3; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LOCOMOTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MORPHOLOGY; MYELINATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; UMBILICAL CORD;

ANALYSIS OF VARIANCE; ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; LOCOMOTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYELIN SHEATH; NERVE REGENERATION; NERVE TISSUE PROTEINS; NEURONS; NEUROTROPHIN 3; PSYCHOMOTOR PERFORMANCE; RATS; SEROTONIN; SPINAL CORD INJURIES; TRANSDUCTION, GENETIC; TYROSINE 3-MONOOXYGENASE; UMBILICAL CORD;

ANIMALIA; RATTUS;

EID: 79955631432     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.03.019     Document Type: Article

References (40)

1. Basso, D.M., Beattie, M.S., Bresnahan, J.C., Anderson, D.K., Faden, A.I., Gruner, J.A., Holford, T.R., Hsu, C.Y., Noble, L.J., Nockels, R., Perot, P.L., Salzman, S.K., Young, W., 1996. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability Multicenter Animal Spinal Cord Injury Study. J. Neurotrauma. 13, 343-359. (Pubitemid 26405758)
2. Boulenguez, P., Vinay, L., 2009. Strategies to restore motor functions after spinal cord injury. Curr. Opin. Neurobiol. 19, 587-600.
3. Bunge, R.P., Puckett, W.R., Becerra, J.L., Marcillo, A., Quencer, R.M., 1993. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 59, 75-89.
4. Can, A., Karahuseyinoglu, S., 2007. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 25, 2886-2895. (Pubitemid 350127873)
5. Chen, M.S., Huber, A.B., van der Haar, M.E., Frank, M., Schnell, L., Spillmann, A.A., Christ, F., Schwab, M.E., 2000. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403, 434-439. (Pubitemid 30073093)
6. Cizkova, D., Novotna, I., Slovinska, L., Vanicky, I., Jergova, S., Rosocha, J., Radonak, J., in press. Repetitive intrathecal catheter delivery of bone marrow mesenchymal stromal cells improves functional recovery in a rat model of contusive spinal cord injury. J Neurotrauma. in press.
7. Das, A. K., Gopurappilly, R., Parhar, I., in press. Current Status and Prospective Application of Stem Cell-Based Therapies for Spinal Cord Injury. Curr. Stem. Cell. Res. Ther. in press.
8. Erdogan, B., Bavbek, M., Sahin, I.F., Caner, H., Ozen, O., Denkbas, E.B., Altinors, M.N., 2010. Fetal allogeneic umbilical cord cell transplantation improvesmotor function in spinal cord-injured rats. Turk. Neurosurg. 20, 286-294.
9. Fan, C.G., Zhang, Q.J., Zhou, J.R., 2011. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev. 7, 195-207.
10. Gruen, L., Grabel, L., 2006. Concise review: scientific and ethical roadblocks to human embryonic stem cell therapy. Stem Cells 24, 2162-2169. (Pubitemid 44527468)
11. Gu, W., Zhang, F., Xue, Q., Ma, Z., Lu, P., Yu, B., 2010. Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord. Neuropathology 30, 205-217.
12. Guo, J.S., Zeng, Y.S., Li, H.B., Huang, W.L., Liu, R.Y., Li, X.B., Ding, Y., Wu, L.Z., Cai, D.Z., 2007. Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury. Spinal Cord 45, 15-24. (Pubitemid 46067396)
13. Hains, B.C., Saab, C.Y., Lo, A.C., Waxman, S.G., 2004. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI. Exp. Neurol. 188, 365-377.
14. Himes, B.T., Liu, Y., Solowska, J.M., Snyder, E.Y., Fischer, I., Tessler, A., 2001. Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats. J. Neurosci. Res. 65, 549-564.
15. Hu, S.L., Luo, H.S., Li, J.T., Xia, Y.Z., Li, L., Zhang, L.J., Meng, H., Cui, G.Y., Chen, Z., Wu, N., Lin, J.K., Zhu, G., Feng, H., 2010. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells. Crit. Care Med. 38, 2181-2189.
16. Johnson, P.J., Parker, S.R., Sakiyama-Elbert, S.E., 2009. Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol. Bioeng. 104, 1207-1214.
17. Kamada, S., Kikkawa, U., Tsujimoto, Y., Hunter, T., 2005. A-kinase-anchoring protein 95 functions as a potential carrier for the nuclear translocation of active Caspase 3 through an enzyme-substrate-like association. Mol. Cell. Biol. 25, 9469-9477.
18. Kitamura, K., Iwanami, A., Nakamura, M., Yamane, J., Watanabe, K., Suzuki, Y., Miyazawa, D., Shibata, S., Funakoshi, H., Miyatake, S., Coffin, R.S., Nakamura, T., Toyama, Y., Okano, H., 2007. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J. Neurosci. Res. 85, 2332-2342.
19. Koda, M., Nishio, Y., Kamada, T., Someya, Y., Okawa, A., Mori, C., Yoshinaga, K., Okada, S., Moriya, H., Yamazaki, M., 2007. Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res. 1149, 223-231. (Pubitemid 46659901)
20. Lu, P., Jones, L.L., Snyder, E.Y., Tuszynski, M.H., 2003. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 181, 115-129.
21. Massey, J.M., Amps, J., Viapiano, M.S., Matthews, R.T., Wagoner, M.R., Whitaker, C.M., Alilain, W., Yonkof, A.L., Khalyfa, A., Cooper, N.G., Silver, J., Onifer, S.M., 2008. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp. Neurol. 209, 426-445.
22. Ohta, M., Suzuki, Y., Noda, T., Ejiri, Y., Dezawa, M., Kataoka, K., Chou, H., Ishikawa, N., Matsumoto, N., Iwashita, Y., Mizuta, E., Kuno, S., Ide, C., 2004. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp. Neurol. 187, 266-278.
23. Pal, R., Gopinath, C., Rao, N.M., Banerjee, P., Krishnamoorthy, V., Venkataramana, N.K., Totey, S., 2010. Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. Cytotherapy 12, 792-806.
24. Parr, A.M., Tator, C.H., Keating, A., 2007. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 40, 609-619. (Pubitemid 47456475)
25. Petsa, A., Gargani, S., Felesakis, A., Grigoriadis, N., Grigoriadis, I., 2009. Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications. In. Vitro. Cell. Dev. Biol. Anim. 45, 573-576.
26. Pincus, D.W., Goodman, R.R., Fraser, R.A., Nedergaard, M., Goldman, S.A., 1998. Neural stem and progenitor cells: a strategy for gene therapy and brain repair. Neurosurgery 42, 858-867 discussion 867-886.
27. Pitzer, C., Klussmann, S., Kruger, C., Letellier, E., Plaas, C., Dittgen, T., Kirsch, F., Stieltjes, B., Weber, D., Laage, R., Martin-Villalba, A., Schneider, A., 2010. The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury. J. Neurochem. 113, 930-942.
28. Saeki, H., Matsumoto, M., Kaneko, S., Tsuruta, S., Cui, Y.J., Ohtake, K., Ishida, K., Sakabe, T., 2004. Is intrathecal magnesium sulfate safe and protective against ischemic spinal cord injury in rabbits? Anesth. Analg. 99, 1805-1812 table of contents.
29. Sahni, V., Kessler, J.A., 2010. Stem cell therapies for spinal cord injury. Nat. Rev. Neurol. 6, 363-372.
30. Sharma, H.S., 2003. Neurotrophic factors attenuate microvascular permeability disturbances and axonal injury following traumato the rat spinal cord. Acta Neurochir. Suppl. 86, 383-388.
31. Shumsky, J.S., Tobias, C.A., Tumolo, M., Long, W.D., Giszter, S.F., Murray, M., 2003. Delayed transplantation of fibroblasts genetically modified to secrete BDNF and NT-3 into a spinal cord injury site is associated with limited recovery of function. Exp. Neurol. 184, 114-130.
32. Sieck, G.C., Mantilla, C.B., 2009. Role of neurotrophins in recovery of phrenic motor function following spinal cord injury. Respir. Physiol. Neurobiol. 169, 218-225.
33. Vaquero, J., Zurita, M., 2009. Bone marrow stromal cells for spinal cord repair: a challenge for contemporary neurobiology. Histol. Histopathol. 24, 107-116.
34. Wright, L.S., Prowse, K.R., Wallace, K., Linskens, M.H., Svendsen, C.N., 2006. Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro. Exp. Cell Res. 312, 2107-2120.
35. Yang, C.C., Shih, Y.H., Ko, M.H., Hsu, S.Y., Cheng, H., Fu, Y.S., 2008. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLoS ONE 3, e3336.
36. Yoshihara, H., Shumsky, J.S., Neuhuber, B., Otsuka, T., Fischer, I., Murray, M., 2006. Combining motor training with transplantation of rat bone marrow stromal cells does not improve repair or recovery in rats with thoracic contusion injuries. Brain Res. 1119, 65-75. (Pubitemid 44647239)
37. Zhang, H.T., Fan, J., Cai, Y.Q., Zhao, S.J., Xue, S., Lin, J.H., Jiang, X.D., Xu, R.X., 2010a. Human Wharton's jelly cells can be induced to differentiate into growth factor-secreting oligodendrocyte progenitor-like cells. Differentiation 79, 15-20.
38. Zhang, J., Li, Y., Chen, J., Cui, Y., Lu, M., Elias, S.B., Mitchell, J.B., Hammill, L., Vanguri, P., Chopp, M., 2005. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp. Neurol. 195, 16-26.
39. Zhang, L., Zhang, H.T., Hong, S.Q., Ma, X., Jiang, X.D., Xu, R.X., 2009. Cografted Wharton's jelly cells-derived neurospheres and BDNF promote functional recovery after rat spinal cord transection. Neurochem. Res. 34, 2030-2039.
40. Zhang, W., Yan, Q., Zeng, Y.S., Zhang, X.B., Xiong, Y., Wang, J.M., Chen, S.J., Li, Y., Bruce, I.C., Wu, W., 2010b. Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord. Brain Res. 1359, 256-271.